Literature DB >> 12864990

Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS.

Jorge Correale1, María de los Milagros Bassani Molinas.   

Abstract

Thirty patients with clinically isolated syndromes (CIS) were evaluated at the onset of neurological symptoms and when they developed clinically definite MS (CDMS). Surface expression of LFA-1alpha, VLA-4 and intercellular adhesion molecule-1 (ICAM-1) on PBMC and CSF cells was evaluated using flow cytometry. Serum and CSF concentrations of soluble vascular cell adhesion molecules-1 (VCAM-1), ICAM-1 and E-Selectin, as well as MMP-9 and MMP-2 serum concentrations were assayed using ELISA. Surface expression of LFA-1alpha and VLA-4 molecules on peripheral blood and CSF T cells and monocytes from CIS and CDMS was significantly increased compared with control subjects. Moreover, LFA-1alpha and VLA-4 expression was significantly higher in patients who developed CDMS compared with those with CIS. Similar changes were observed in the serum levels of MMP-9. Furthermore, patients with CIS and CDMS had significantly higher levels of CSF sVCAM and s-E-Selectin than control subjects. These data suggest that VLA-4, LFA-1alpha and MMP-9 play a leading role in the evolution of inflammatory demyelinating lesions in patients with CIS who develop CDMS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12864990     DOI: 10.1016/s0165-5728(03)00204-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis.

Authors:  Jameel Dennis; Daniel T Meehan; Duane Delimont; Marisa Zallocchi; Greg A Perry; Stacie O'Brien; Hongmin Tu; Taina Pihlajaniemi; Dominic Cosgrove
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

3.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

4.  The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.

Authors:  Srdjan Ljubisavljevic; I Stojanovic; J Basic; S Vojinovic; D Stojanov; G Djordjevic; D Pavlovic
Journal:  J Mol Neurosci       Date:  2015-02-22       Impact factor: 3.444

5.  Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.

Authors:  Carlos Camara-Lemarroy; Luanne Metz; Jens Kuhle; David Leppert; Eline Willemse; David Kb Li; Anthony Traboulsee; Jamie Greenfield; Graziela Cerchiaro; Claudia Silva; V Wee Yong
Journal:  Mult Scler       Date:  2022-07-18       Impact factor: 5.855

6.  Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

Authors:  J Sellner; W Koczi; A Harrer; K Oppermann; E Obregon-Castrillo; G Pilz; P Wipfler; S Afazel; E Haschke-Becher; E Trinka; J Kraus
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

7.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Authors:  Stefan M Gold; Manda V Sasidhar; Laurie B Morales; Sienmi Du; Nancy L Sicotte; Seema K Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

8.  Concentration of soluble adhesion molecules in cerebrospinal fluid and serum of epilepsy patients.

Authors:  Jing Luo; Wei Wang; Zhiqin Xi; Chen Dan; Liang Wang; Zheng Xiao; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

9.  Forecasting the cytokine storm following systemic interleukin (IL)-2 administration.

Authors:  Monica C Panelli; Richard White; Mareva Foster; Brian Martin; Ena Wang; Kina Smith; Francesco M Marincola
Journal:  J Transl Med       Date:  2004-06-02       Impact factor: 5.531

10.  Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.

Authors:  Adriana C Dos Santos; Ester Roffê; Rosa M E Arantes; Luiz Juliano; Jorge L Pesquero; João B Pesquero; Michael Bader; Mauro M Teixeira; Juliana Carvalho-Tavares
Journal:  J Neuroinflammation       Date:  2008-11-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.